School-based screening and treatment may reduce P. falciparum transmission

Lauren M Cohee, Clarissa Valim, Jenna E Coalson, Andrew Nyambalo, Moses Chilombe, Andrew Ngwira, Andy Bauleni, Karl B Seydel, Mark L Wilson, Terrie E Taylor, Don P Mathanga, Miriam K Laufer, Lauren M Cohee, Clarissa Valim, Jenna E Coalson, Andrew Nyambalo, Moses Chilombe, Andrew Ngwira, Andy Bauleni, Karl B Seydel, Mark L Wilson, Terrie E Taylor, Don P Mathanga, Miriam K Laufer

Abstract

In areas where malaria remains entrenched, novel transmission-reducing interventions are essential for malaria elimination. We report the impact screening-and-treatment of asymptomatic Malawian schoolchildren (n = 364 in the rainy season and 341 in the dry season) had on gametocyte-the parasite stage responsible for human-to-mosquito transmission-carriage. We used concomitant household-based surveys to predict the potential reduction in transmission in the surrounding community. Among 253 students with P. falciparum infections at screening, 179 (71%) had infections containing gametocytes detected by Pfs25 qRT-PCR. 84% of gametocyte-containing infections were detected by malaria rapid diagnostic test. While the gametocyte prevalence remained constant in untreated children, treatment with artemether-lumefantrine reduced the gametocyte prevalence (p < 0.0001) from 51.8 to 9.7% and geometric mean gametocyte density (p = 0.008) from 0.52 to 0.05 gametocytes/microliter. In community surveys, 46% of all gametocyte-containing infections were in school-age children, who comprised only 35% of the population. Based on these estimates six weeks after the intervention, the gametocyte burden in the community could be reduced by 25-55% depending on the season and the measure used to characterize gametocyte carriage. Thus, school-based interventions to treat asymptomatic infections may be a high-yield approach to not only improve the health of schoolchildren, but also decrease malaria transmission.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Baseline weighted proportion of students with P. falciparum infection detected by PCR (×) and the weighted proportion of students with gametocyte-containing infections detected (black bar) and not detected (grey bar) by rapid diagnostic test in school-based cohorts.
Figure 2
Figure 2
Impact of treating RDT positive students on the proportion and density of gametocytes in the school-based cohort over time. Proportion of students with gametocytes in all schools combined (a) and by school in the rainy (c) and the dry (d) season. Mean gametocyte density (logarithm transformed) among students in all schools (b) and by school in the rainy (e) and the dry (f) season. Solid lines represent students who received treatment; Dashed lines represent students who did not receive treatment. Color designates season in a and b rainy (black) and dry (gray). Color designates school in c-f Bvumbwe (yellow), Ngowe (red), Maseya (blue), Makhuwira (green). Both estimates were obtained in random effects longitudinal analysis (full models in Supplemental Tables S3 and S4).
Figure 3
Figure 3
Predicted impact of school-based treatment of RDT positive students on the population of gametocytes in the surrounding community. Following school-based screening-and-treatment at baseline, the estimated impact on gametocyte prevalence (a in rainy and b in dry seasons), total gametocyte burden (c in rainy and d in dry seasons), and number of infections containing ≥ 10 gametocytes/µl (e in rainy and f in dry seasons) in the communities surrounding the schools are predicted at one, two, and six weeks after the intervention. Color indicates the proportion of the gametocyte measure by age group: school-age children (6-15y)—black; younger children (6 m-5y)—light grey; adults (> 15y)—dark grey. Total gametocyte burden is the sum of gametocyte densities in individuals in each age group. These calculations assume treatment is not provided to young children, adults, or school-age children who test negative by RDT when the intervention is implemented. Reduction is calculated as the proportional difference between the baseline and six-weeks post intervention.

References

    1. World Health Organization. World Malaria Report 2019. Geneva. (2019). Licence: CC BY-NC-SA 3.0 IGO
    1. WHO. Global technical strategy for malaria 2016–2030. World Health Organization (2015).
    1. Rabinovich RN, et al. malERA: An updated research agenda for malaria elimination and eradication. PLOS Med. 2017;14:e1002456. doi: 10.1371/journal.pmed.1002456.
    1. Barry, A. et al. Increased gametocyte production and mosquito infectivity in chronic versus incident Plasmodium falciparum infections. medRxiv (2020). 10.1101/2020.04.08.20057927
    1. Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: Detectability, transmissibility and public health relevance. Nat. Rev. Microbiol. 2014;12:833–840. doi: 10.1038/nrmicro3364.
    1. malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication. PLoS Med.14, (2017).
    1. Nankabirwa J, et al. Malaria in school-age children in Africa: An increasingly important challenge. Trop. Med. Int. Health. 2014 doi: 10.1111/tmi.12374.
    1. Stone W, Gonçalves BP, Bousema T, Drakeley C. Assessing the infectious reservoir of falciparum malaria: Past and future. Trends Parasitol. 2015 doi: 10.1016/j.pt.2015.04.004.
    1. Walldorf JA, et al. School-age children are a reservoir of malaria infection in Malawi. PLoS ONE. 2015;10:e0134061. doi: 10.1371/journal.pone.0134061.
    1. Nankabirwa JI, et al. Estimating malaria parasite prevalence from community surveys in Uganda: A comparison of microscopy, rapid diagnostic tests and polymerase chain reaction. Malar. J. 2015;14:528. doi: 10.1186/s12936-015-1056-x.
    1. Zhou Z, et al. Assessment of submicroscopic infections and gametocyte carriage of Plasmodium falciparum during peak malaria transmission season in a community-based cross-sectional survey in western Kenya, 2012. Malar. J. 2016;15:421. doi: 10.1186/s12936-016-1482-4.
    1. Mwandagalirwa MK, et al. Individual and household characteristics of persons with Plasmodium falciparum malaria in sites with varying endemicities in Kinshasa Province, Democratic Republic of the Congo. Malar. J. 2017;16:1–12. doi: 10.1186/s12936-017-2110-7.
    1. Pinchoff J, et al. Individual and household level risk factors associated with malaria in Nchelenge District, a region with perennial transmission: A serial cross-sectional study from 2012 to 2015. PLoS ONE. 2016;11:e0156717. doi: 10.1371/journal.pone.0156717.
    1. Coalson JE, et al. High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: Patterns and predictors of risk from a cross-sectional study in southern Malawi. Malar J. 2016;15:1–17. doi: 10.1186/s12936-016-1587-9.
    1. Lin Ouédraogo A, et al. Dynamics of the human infectious reservoir for malaria determined by mosquito feeding assays and ultrasensitive malaria diagnosis in Burkina Faso. J. Infect. Dis. 2015;213:90–99. doi: 10.1093/infdis/jiv370.
    1. Noor AM, Kirui VC, Brooker SJ, Snow RW. The use of insecticide treated nets by age: Implications for universal coverage in Africa. BMC Public Health. 2009;9:369. doi: 10.1186/1471-2458-9-369.
    1. Buchwald AG, et al. Bed net use among school-aged children after a universal bed net campaign in Malawi. Malar. J. 2016;15:127. doi: 10.1186/s12936-016-1178-9.
    1. Port GR, Boreham PF. The relationship of host size to feeding by mosquitoes of the Anopheles gambiae Giles complex (Diptera: Culicidae) Bull. Entomol. Res. 1980;70:133–144. doi: 10.1017/S0007485300009834.
    1. Gonçalves BP, et al. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. Nat. Commun. 2017;8:1133. doi: 10.1038/s41467-017-01270-4.
    1. Coalson JE, et al. Simulation models predict that school-age children are responsible for most human-to-mosquito Plasmodium falciparum transmission in southern Malawi. Malar J. 2018;17:1–12. doi: 10.1186/s12936-018-2295-4.
    1. Cissé B, et al. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med. 2016;13:e1002175. doi: 10.1371/journal.pmed.1002175.
    1. Cohee, L. M. et al. Preventive malaria treatment among school-age children in sub-Saharan Africa: A systematic review and meta-analyses. Lancet Glob. Heal. (2020, in press).
    1. Clarke SE, et al. Impact of a malaria intervention package in schools on Plasmodium infection, anaemia and cognitive function in schoolchildren in Mali: A pragmatic cluster-randomised trial. BMJ Glob. Heal. 2017;2:e000182. doi: 10.1136/bmjgh-2016-000182.
    1. Stuckey EM, et al. Modeling the cost effectiveness of malaria control interventions in the highlands of Western Kenya. PLoS ONE. 2014;9:e107700. doi: 10.1371/journal.pone.0107700.
    1. Staedke SG, et al. Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): A cluster-randomised trial. Lancet Glob. Heal. 2018;6:e668–e679. doi: 10.1016/S2214-109X(18)30126-8.
    1. Bradley J, et al. Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte density. Elife. 2018;7:e34463. doi: 10.7554/eLife.34463.
    1. Uniting to Combat Neglected Tropical Diseases. Impact dashboard for preventive chemotherapy (PC) diseases. (2019). . (2020)
    1. Muirhead-Thompson R. Distribution of anopheline mosquito bites among different age groups. Br. Med. J. 1951;1:1114. doi: 10.1136/bmj.1.4715.1114.
    1. Greenwood BM, et al. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans. R. Soc. Trop. Med. Hyg. 1995;89:629–633. doi: 10.1016/0035-9203(95)90419-0.
    1. Bradley-Moore AM, et al. Malaria chemoprophylaxis with chloroquine in young Nigerian children. I. Its effect on mortality, morbidity and the prevalence of malaria. Ann. Trop. Med. Parasitol. 1985;79:549–562. doi: 10.1080/00034983.1985.11811962.
    1. Dicko A, et al. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar. J. 2008;7:123. doi: 10.1186/1475-2875-7-123.
    1. Macete E, et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in mozambican infants: a randomized, placebo-controlled trial. J. Infect. Dis. 2006;194:276–285. doi: 10.1086/505431.
    1. Real time RT-PCR for presence and quantification of Plasmodium gametocytes from peripheral blood samples in RNAprotect. (2020).
    1. R Development Core Team. R: A language and environment for statistical computing. (R Foundation for Statistical Computing, 2020).

Source: PubMed

3
Předplatit